Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-274,887
Closed -$26M 34
2023
Q1
$26M Sell
274,887
-114,407
-29% -$10.9M 3.24% 15
2022
Q4
$33.2M Sell
389,294
-44,108
-10% -$3.62M 4.88% 5
2022
Q3
$27.5M Buy
433,402
+62,629
+17% +$4.85M 5.05% 8
2022
Q2
$26.6M Buy
+370,773
New +$28.9M 5.02% 10

Other funds holding MTZ

M.D. Sass LLC's MTZ Position: Q2 2023 in Review

M.D. Sass LLC sold out of MasTec (MTZ) in Q2 2023, closing a stake of 274,887 shares — an estimated $26M sold.

M.D. Sass LLC first reported a position in MTZ in Q2 2022 and held it in 4 quarters. The position peaked at $33.2M in Q4 2022. 392 funds tracked by Wall St. Rank hold MTZ as of Q2 2023.

  • M.D. Sass LLC reported no remaining MasTec position as of Q2 2023 after selling out during the quarter.
  • M.D. Sass LLC sold 274,887 MasTec shares in Q2 2023, an estimated $26M.
  • M.D. Sass LLC first reported a position in MasTec in Q2 2022 and held it in 4 quarters.
  • M.D. Sass LLC's MasTec position peaked at $33.2M in Q4 2022.
  • 392 funds tracked by Wall St. Rank held MasTec as of Q2 2023.

Based on M.D. Sass LLC's 13F filing for Q2 2023, filed 10 Aug 2023.